A new method, dubbed DREADDs, relies on gene therapy techniques to alter genes in target cells to change the cell's behavior. The method reduced anxious behaviors in monkey models of schizophrenia when combined with clozapine. Researchers say the method has the potential for use in humans to help reduce anxiety.
Researchers report that temporarily turning off an area of the brain changes patterns of activity across much of the remaining brain.
Activating designer neural receptors can suppress cravings in the ventral pallidum, a new study reports.